S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Biden's State of the Union to tout policy wins on economy
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
How will EU ban and West's price cap on Russian diesel work?
Evacuations urged in Ohio town as train wreck smolders
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
'Knock at the Cabin' knocks off 'Avatar' at the box office
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Biden's State of the Union to tout policy wins on economy
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
How will EU ban and West's price cap on Russian diesel work?
Evacuations urged in Ohio town as train wreck smolders
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
'Knock at the Cabin' knocks off 'Avatar' at the box office
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Biden's State of the Union to tout policy wins on economy
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
How will EU ban and West's price cap on Russian diesel work?
Evacuations urged in Ohio town as train wreck smolders
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
'Knock at the Cabin' knocks off 'Avatar' at the box office
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Biden's State of the Union to tout policy wins on economy
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
How will EU ban and West's price cap on Russian diesel work?
Evacuations urged in Ohio town as train wreck smolders
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
'Knock at the Cabin' knocks off 'Avatar' at the box office
LON:AVO

Advanced Oncotherapy - AVO Share Forecast, Price & News

GBX 9.75
0.00 (0.00%)
(As of 02/3/2023 12:00 AM ET)
Add
Compare
Today's Range
9.50
▼
10
50-Day Range
9.75
▼
17.10
52-Week Range
9.50
▼
32
Volume
501,943 shs
Average Volume
593,889 shs
Market Capitalization
£52.40 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
AVO stock logo

About Advanced Oncotherapy (LON:AVO) Stock

Advanced Oncotherapy plc, together with its subsidiaries, engages in the designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties. It has operations in the United Kingdom, Switzerland, and the United States. The company was formerly known as CareCapital Group plc and changed its name to Advanced Oncotherapy PLC in September 2012. Advanced Oncotherapy plc was founded in 1994 and is headquartered in London, the United Kingdom.

Receive AVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Advanced Oncotherapy and its competitors with MarketBeat's FREE daily newsletter.

AVO Stock News Headlines

January 27, 2023 | finanznachrichten.de
Hardman & Co Research: Q&A on Advanced Oncotherapy (AVO): Current EV significantly below cumulative investment to date
January 3, 2023 | finance.yahoo.com
Independent Non-Executive Director Michael Bradfield Just Bought 6.4% More Shares In Advanced Oncotherapy plc (LON:AVO)
February 5, 2023 | Investor Place Media (Ad)
Cash Holders STILL Aren't Taking Steps to Prepare
Stocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.
December 13, 2022 | marketwatch.com
Advanced Oncotherapy Raises GBP1.5 Mln Via High-Premium Share Subscription
October 27, 2022 | proactiveinvestors.com
Proactive news headlines: Deepverge, Greatland Gold, Seeing Machines, and more
September 29, 2022 | uk.finance.yahoo.com
Hardman & Co Research on Advanced Oncotherapy: Major milestone achieved
September 8, 2022 | finance.yahoo.com
Advanced Oncotherapy plc (LON:AVO) has caught the attention of institutional investors who hold a sizeable 39% stake
August 1, 2022 | finance.yahoo.com
Is Now An Opportune Moment To Examine Advanced Oncotherapy plc (LON:AVO)?
February 5, 2023 | Investor Place Media (Ad)
Cash Holders STILL Aren't Taking Steps to Prepare
Stocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.
July 2, 2022 | finance.yahoo.com
Calculating The Intrinsic Value Of Advanced Oncotherapy plc (LON:AVO)
March 31, 2022 | proactiveinvestors.com
Advanced Oncotherapy's technology can slash costs of proton therapy cancer treatment says CEO
March 26, 2022 | proactiveinvestors.com.au
Proactive weekly mining highlights: Horizonte, Atlantic Lithium, East Star and more
March 25, 2022 | proactiveinvestors.com
Advanced Oncotherapy raises £2mln at a premium
March 1, 2022 | proactiveinvestors.com
FTSE 100 in the red as fighting in Ukraine is intensifying with Russia
March 1, 2022 | proactiveinvestors.com
Advanced Oncotherapy hails significant progress with regulatory submission as it updates on its timeline
February 25, 2022 | finance.yahoo.com
Advanced Oncotherapy plc (AVO.L)
December 13, 2021 | proactiveinvestors.com
Advanced Oncotherapy says it is making good progress, but confirms previously-flagged delay
November 15, 2021 | markets.businessinsider.com
Hardman & Co Research: Advanced Oncotherapy (AVO): On the home straight
October 2, 2021 | finance.yahoo.com
Is Advanced Oncotherapy plc (LON:AVO) Popular Amongst Insiders?
September 2, 2021 | proactiveinvestors.com
Advanced Oncotherapy - Result of GM, TVR and clarification re warrants
August 12, 2021 | markets.businessinsider.com
Advanced Oncotherapy : Result of AGM
August 12, 2021 | finanznachrichten.de
Hardman & Co Research: Advanced Oncotherapy (AVO) Funded to completion
August 11, 2021 | proactiveinvestors.com
Advanced Oncotherapy - Proposed subscription and issuance of shares
June 30, 2021 | proactiveinvestors.com
Advanced Oncotherapy says 2021 to be important year
June 3, 2021 | proactiveinvestors.com
Advanced Oncotherapy signs initial deal to provide LIGHT system treatment rooms for £75.5mln
May 29, 2021 | markets.businessinsider.com
Advanced Oncotherapy : Total Voting Rights
March 22, 2021 | proactiveinvestors.com
Advanced Oncotherapy present research potentially offering 'powerful weapon to resistant cancers'
See More Headlines
Receive AVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Advanced Oncotherapy and its competitors with MarketBeat's FREE daily newsletter.

AVO Company Calendar

Last Earnings
6/29/2020
Today
2/05/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Medical Devices
Sub-Industry
N/A
Sector
Medical
Current Symbol
LON:AVO
CUSIP
N/A
CIK
N/A
Web
www.advancedoncotherapy.com
Phone
+44-20-36178728
Fax
N/A
Employees
139
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
98.71
Current Ratio
1.26
Quick Ratio
0.13

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
GBX 0.29 per share
Price / Cash Flow
33.50
Book Value
GBX 13.60 per share
Price / Book
0.72

Miscellaneous

Outstanding Shares
537,481,000
Free Float
N/A
Market Cap
£52.40 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Dr. Michael Jeffrey Sinclair (Age 79)
    Exec. Chairman
    Comp: $434.42k
  • Mr. Nicolas Serandour
    CEO & Exec. Director
  • Prof. Stephen Myers OBE (Age 75)
    Exec. Director
    Comp: $397.72k
  • Mr. Ed Lee
    COO & Pres of Europe
  • Mr. Graham Pughe
    Sr. Vice-Pres of Accounting
  • Ms. Berengere Pons-Chabord
    Sr. Vice-Pres of Corp. Fin.
  • Dr. Manuel Gallas
    Director of Technical & Engineering
  • Mr. David Navas
    VP of Investor and PR
  • Ms. Bridget Biggar
    Director of HR
  • Ms. Donatella Ungaro
    Managing Director of ADAM

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions













AVO Stock - Frequently Asked Questions

How have AVO shares performed in 2023?

Advanced Oncotherapy's stock was trading at GBX 13.50 at the beginning of the year. Since then, AVO shares have decreased by 27.8% and is now trading at GBX 9.75.
View the best growth stocks for 2023 here.

How were Advanced Oncotherapy's earnings last quarter?

Advanced Oncotherapy plc (LON:AVO) released its earnings results on Monday, June, 29th. The company reported ($9.83) EPS for the quarter, missing analysts' consensus estimates of ($8.90) by $0.93.

What other stocks do shareholders of Advanced Oncotherapy own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Advanced Oncotherapy investors own include UK Oil & Gas (UKOG), Avesoro Resources (ASO), Oxford Biomedica (OXB), BMR Group (BMR), GW Pharmaceuticals (GWPH), Lancashire (LRE), Sirius Minerals (SXX), Renishaw (RSW), Scancell (SCLP) and Tullow Oil (TLW).

What is Advanced Oncotherapy's stock symbol?

Advanced Oncotherapy trades on the London Stock Exchange (LON) under the ticker symbol "AVO."

How do I buy shares of Advanced Oncotherapy?

Shares of AVO stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Advanced Oncotherapy's stock price today?

One share of AVO stock can currently be purchased for approximately GBX 9.75.

How much money does Advanced Oncotherapy make?

Advanced Oncotherapy (LON:AVO) has a market capitalization of £52.40 million.

How many employees does Advanced Oncotherapy have?

The company employs 139 workers across the globe.

How can I contact Advanced Oncotherapy?

Advanced Oncotherapy's mailing address is Third Fl Clearwater HSE, 4-7 Manchester Street, LONDON, W1U 3AE, United Kingdom. The official website for the company is www.advancedoncotherapy.com. The company can be reached via phone at +44-20-36178728.

This page (LON:AVO) was last updated on 2/5/2023 by MarketBeat.com Staff